pharmaceutical reports

Pharmaceutical CDMO Services on the Rise

13 February 2020
Pharma
pharmaceutical reports

The pharmaceutical market is one of today’s fastest-growing industries, which is why the professionals from Visiongain have made it their business to help companies and stakeholders stay up to date. One sector experiencing significant growth is that of contract development and manufacturing organization (CDMO) services.

Here you’ll find all you need to know about this fast-growing sector of the pharmaceutical industry and how investors can be poised to generate big returns in the years ahead.

What Exactly Do CDMOs Do?

Before jumping into some of the benefits of investing in CDMO services, it’s important to have a clear idea of their function in the pharmaceutical industry. Basically, CDMOs provide companies in the pharmaceutical industry with some of the key components necessary to bring a drug or treatment to the market. They’re responsible for the research, manufacturing, and development services necessary for companies to produce specialized drugs and other pharmaceutical products.

Why Do CDMOs Have Such a Significant Market Segment?

CDMOs make up a substantial segment of the pharmaceutical market these days for several reasons, the first being that they help ensure drug manufacturers that all of the products they produce are of the highest possible quality. By contract manufacturing, pharma companies can ensure that the proper quality standards, performance measures, and safety regulations are followed during the manufacturing of their products. This in turn not only provides added oversight into the manufacturing process but also helps manufacturers save on research and development costs.

Trends & Opportunities in the Global CDMO Market

One of the leading opportunities in the global CDMO market is the need for such services in various regions due to existing supply-demand deficits. Additionally, with the expanded development of generic drugs, more pharmaceutical companies are looking to minimize production costs while simultaneously taking advantage of such deficits, making working with CDMOs ever more popular. Some of the key regions that are experiencing significant growth include Europe, due to a more practical and businesslike approach to contract production, and the Asia-Pacific region due to the larger populations in areas such as India and China.

Let us provide the pharmaceutical reports & insights you need to excel!

If you want to keep up with all of the current trends and changes in the pharmaceutical industry, the team from Visiongain has the information you need. All of our reports are based on comprehensive primary and secondary sources and are compiled by knowledgeable industry experts. With more than 1,500 reports available spanning over 18 market verticals, Visiongain has developed a reputation in the market research industry for providing the essential information necessary for businesses to experience long-term success.

To learn more about what we do, contact us online today or call +44 (0) 20 7549 9987.

Recent News

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever